<DOC>
	<DOCNO>NCT02591823</DOCNO>
	<brief_summary>Low dose methotrexate use rheumatoid arthritis consider safe side effect profile different see high dose methotrexate use oncology . Hair fall find occur high dose methotrexate data regard methotrexate use low dose.Thus observational case control study undertaken determine whether rheumatoid arthritis patient really need concerned hair fall low dose methotrexate .</brief_summary>
	<brief_title>Hair Fall Patients Low Dose Methotrexate</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>For Cases Subjects 18 year age . Diagnosed rheumatoid arthritis fulfil ACR EULAR 2010 criterion . Should initiated methotrexate Willing follow For Controls Subjects 18 year age . For Cases Subjects prior exposure methotrexate last 6 month Subjects suffer Thyroid ( hypothyroidism ) Subjects leflunomide , receive leflunomide last 6 month Subjects currently cyclophosphamide receive cyclophosphamide last 3 month . Subjects psychiatric treatment depression illness . Subjects overlap rheumatological disorder cause hair fall . Subjects 15 month postpartum postnatal period . Subjects female pattern baldness Subjects androgenetic alopecia Subjects alopecia aereta Subjects scalp condition predispose hair fall For Controls Subjects family history alopecia . Subjects suffer thyroid . Subjects history anemia . Subjects 15 month postpartum postnatal period . Subjects medication cause hair fall . Subjects methotrexate reason . Subjects female pattern baldness Subjects androgenetic alopecia Subjects alopecia aereta Subjects scalp condition predispose hair fall</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>